Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) - Share price - Overview

Stock Report

Lexicon Pharmaceuticals Inc LXRX

Last Price
$14.35

Day Change
-0.16|-1.10%

As of 17/08/2017
16:53:08 EDT | USD
Minimum 15 Minutes Delay.

Last Close14.51
Day Range14.33 - 14.79
Mkt Cap1.52Bil
52-Wk Range13.41 - 19.62
Yield %-
ISINUS5288723027
Volume599,638
P/E-10.79
P/S18.48
P/CF-7.43

Share Price

Financials
201420152016
More ...
Income Statement
Revenue22.85130.0183.34
Operating Income-100.371.47-137.16
Net Income-100.29-4.68-141.43
Basic EPS-1.33-0.05-1.36
Avg. Diluted Shares Outstanding76104104
Balance Sheet
Current Assets368.99532.40357.87
Non Current Assets102.39122.43117.75
Total Assets471.38654.83475.63
Current Liabilities44.97123.00164.64
Total Liabilities187.36368.98318.22
Total Equity284.02285.85157.40
Cash Flow
Operating Cash Flow-75.62184.78-175.63
Capital Expenditure-0.08-0.91-0.23
Free Cash Flow-75.70183.87-175.86

In millions, except "Basic EPS". Currency is USD.

Company Profile

Lexicon Pharmaceuticals Inc operates as a biopharmaceutical company engaged in discovery and development of breakthrough treatments for human disease. The company mainly designs and develops drugs for therapeutic areas.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

168
Key Stats
More ...
Price/Earning TTM-10.91
Price/Book14.41
Price/Sales TTM16.94
Rev Growth (3 year avg)234.73
EPS Growth (3 year avg)-
Operating Margin % TTM-164.58
Net Margin % TTM-169.71
ROE TTM-63.81
Debt/Equity0.54
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.